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Deoxyepothilone B (Sloan-Kettering/Kosan/Roche) andWhat Makes Epothilones Stick?
C21-amino epothilone B (BMS) have also entered clini-
cal trials [12].
Previous authors have made extensive studies of the
SAR of the epothilones, as summarized in the reviewsThe potent epothilone tubulin polymerization promot-
cited [9,10]. The study by Buey et al. [13] goes beyonders have been studied extensively by synthetic and
these studies to provide an in-depth look at why certainSAR approaches. The paper by Buey et al. ([13], this
structural modifications result in increased activity andissue of Chemistry & Biology) adds a new depth of
why others give reduced activity. The authors do thismechanistic understanding by a careful analysis of the
by a careful analysis of the binding affinity of epothilonetubulin polymerization mechanism of the epothilones.
analogs to microtubules and by correlating this affinity
with cytotoxicity. This paper is thus the first in whichThe discovery in 1979 of the ability of paclitaxel (Taxol)
the microtubule binding of epothilones has been studiedto promote the polymerization of tubulin heterodimers
at a fundamental level.to microtubules [1] marked a turning point in the devel-
The major problem with studies of the interaction ofopment of this compound as an anticancer agent, and
paclitaxel and paclitaxel-like compounds with tubulin isit went on to become a blockbuster drug. Paclitaxel’s
that they are too good at what they do. They bind tosuccess initiated a search for other anticancer agents
the polymerized form of tubulin and immediately inducethat operate by the same mechanism, and several com-
further assembly so that it is not possible to study tubulinpounds that do this have been found, including discod-
binding apart from microtubule assembly; the two reac-ermolide [2], eleutherobin [3], and several other natural
tions are inseparably linked. The present authors haveproducts. Of all the “paclitaxel-like” compounds found
previously developed a way around this difficulty by theto date, however, the epothilones have excited the most
use of microtubules stabilized by gentle crosslinkinginterest. Epothilones A (Figure 1[1]) and B (Figure 1[2])
and by the use of fluorescent paclitaxel probes. Thesewere originally isolated as antifungal agents, but scien-
conditions allow the study of the ligand-microtubule in-tific interest in them was enormously stimulated by the
teraction at low enough concentrations to obtain directdiscovery of their tubulin-polymerization activity in 1995
measurements of the binding affinity, and nonfluores-[4] and by the publication of their complete structure
cent ligands can be studied by competition with theand stereochemistry [5]. Biological studies of the epothi-
fluorescent probes.lones have shown that they stabilize microtubules in the
In the present study, the authors applied these meth-same way that paclitaxel does but with somewhat higher
ods to the study of the binding of epothilones A and Bpotencies. Not only do they act as tubulin-polymeriza-
and various epothilone analogs to microtubules. Directtion agents in the same way that paclitaxel does, but
binding constants were calculated, and the reactionsthey also compete for the same binding site on the
were carried out at various temperatures so that Hpolymer, since they act as competitive inhibitors of the
and S values could be calculated for each ligand. Thebinding of [3H]paclitaxel to tubulin polymers [6]. In addi-
binding affinity results are presented graphically in ation, epothilone B has been shown to be superior to
paclitaxel in treating vinblastine-resistant CCRF-CEM
tumors in the mouse [7], and desoxyepothilone B is
curative against paclitaxel-resistant CCRF-CEM tumors
[8]. Several total and partial syntheses of the epothilones
and their analogs have been reported, and extensive
SAR studies have been carried out. Their chemistry and
biology have been reviewed, with two important reviews
by one of the coauthors of the present paper [9, 10].
Epothilone B is the most potent antiproliferative agent
among the naturally occurring tubulin polymerization
promoters, with an activity from 2- to 10-fold greater
than that of paclitaxel, and it is less susceptible than
paclitaxel to Pgp- mediated MDR [11]. Epothilone B is
Figure 1. Epothilones A and Bin phase II trials by Novartis, and its lactam analog BMS-
247550 is in phase II/III trials by Bristol-Myers Squibb. Structures of Epothilone A and Epothilone B.
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Figure 2. Design of Epothilone Analogs
Structure-activity relationships for microtu-
bule binding of C12, cyclopropyl, and C15
side chain epothilone analogs.
visual format, where the position of a structure in the ship between ligand binding and microtubule stabiliza-
figure is related both to its binding affinity and to its tion activity. It was found that these values correlated
structure. fairly well. As expected, compound 19, with the strong-
So what did these studies reveal? At a basic level est microtubule binding affinity, was also the strongest
the findings agree with earlier results, confirming, for inducer of microtubule assembly, and the same was
example, that the S stereochemistries at C13 and C15 true in reverse for the analog with the weakest binding
are crucial, while that at C12 can be either R or S. Re- affinity.
placement of the epoxide with a cyclopropane ring en- All this is very interesting, but at the end of the day
hances binding affinity, as does replacement of the C21 an analog must be able to induce cancer cell death, and
methyl group with a thiomethyl group. These findings so it is the cytotoxicity of the epothilones that primarily
are summarized in Figure 2. determines their value as drug candidates. A compound
The analog with the greatest binding affinity was found with excellent binding characteristics that was only
to be compound 19 (Figure 3), with both the cyclopro- weakly cytotoxic would probably not be of great interest.
pane ring and thiomethyl substitutions on the epothilone The authors thus compared their binding affinity data
B skeleton; this compound had about 25 times the bind- with cytotoxicity data, using the 1A9 human ovarian
ing affinity of epothilone B itself. carcinoma cell line. They found that cytotoxicity paral-
An analysis of the factors behind the observed SAR leled binding affinity to a reasonable approximation, and
proved instructive. Thus the change of the C21 methyl compound 19 was indeed the most potent analog
to thiomethyl, which was favorable overall, was actually tested. Interestingly, however, compounds such as 19,
unfavorable in the enthalpy term but highly favorable in which owed their increased binding affinity in part to a
the entropy term, thus making the overall reaction an favorable entropic term, were not as potent cytotoxins
entropy-driven one. It is suggested that the sulfur atom as their binding affinity would have predicted. Although
places the methyl group in a better position for a hy- compound 19, for example, had a binding affinity 25
drophobic interaction. In the pyridine series, however, times larger than epothilone B, it was only three times
the change of methyl to thiomethyl proved unfavorable; more cytotoxic than the latter.
presumably in this case the sulfur places the methyl The authors point out that their method of measuring
group in an unfavorable location. Another conclusion binding affinities is simpler and more sensitive to struc-
was that the changes were largely additive, so that the tural changes than the measurement of critical concen-
effect of making two modifications could usually be pre- trations. They thus rightly claim that the measurement
dicted from the effects of the individual modifications. of binding affinities is a better design tool than measure-
Since the normal effect of ligand binding is microtu- ment of microtubule stabilization. They go on to state
bule stabilization, a study was also done on the relation- that future improvements in cytotoxicity could be made
most effectively by the preparation of compounds with
increased enthalpic contributions to their binding affin-
ity. Regrettably, the authors do not provide any insight
as to how this might be done, but they have provided
a useful tool for others to take advantage of.
David G.I. Kingston
Department of Chemistry
M/C 0212
Figure 3. Compound 19 Virginia Polytechnic Institute and State University
Blacksburg, Virginia 24061Structure of the high-affinity epothilone analog compound 19.
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of novel compounds. These systems contain a set ofNew Start and Finish
enzymes or modules for every cycle of chain extension,for Complex Polyketide as well as a loading module for transferring the starter
acyl group onto the first KS domain. This modular orga-Biosynthesis
nization allows programmed assembly of a defined se-
quence of starter and extender units, together with con-
trolled processing of each -ketone group. The final
The polyketide vicenistatin has significant anticancer product may be cyclized by a thioesterase (TE) to give
activity. In the January issue of Chemistry & Biology, a macrolactone.
Kakinuma and coworkers [20] reported on the viceni- Starter units may derive from acyl CoAs that are re-
statin biosynthetic gene cluster and demonstrated in cruited from primary metabolism and used directly. Ace-
vitro glycosylation of its aglycone core, raising the tyl and propionyl starters can also be generated by de-
possibility of producing analogs with altered sugar carboxylation of malonyl and methylmalonyl groups
residues. attached to loading module ACPs. Other more unusual
organic acids are activated as acyl adenylates before
The polyketide group of natural products includes nu- transfer to CoA or an ACP [3]. Modular PKSs generally
merous antibiotics, anticancer drugs, and immunosup- use malonyl and methylmalonyl-CoA as extender units.
pressants. Biosynthesis of these important compounds Ethylmalonyl and methoxymalonyl units are used less
involves assembly of carbon chains from small acyl pre- frequently [4]. The sequences of malonyl and methylmal-
cursors. In general, chain elongation is catalyzed by onyl-specific AT domains can be distinguished by char-
a set of enzymes that together make up a polyketide acteristic motifs. A separate region of the AT domain
synthase (PKS). A starter or growing acyl chain migrates contains critical residues that appear to determine sub-
onto the active site cysteine of a ketosynthase (KS), strate specificity. Methylmalonate-specific AT domains
and an acyltransferase (AT) loads a dicarboxylic acyl use only the (2S) isomer of methylmalonyl CoA [5]. When
extender unit onto the phosphopantetheine thiol of an this branched extender is used, condensation occurs
acyl carrier protein (ACP). A decarboxylative Claisen with inversion of stereochemistry at C-2 so that a (2R)
condensation leaves an extended -ketoacyl chain 2-methyl-3-ketoacyl chain is generated initially [6]. With
attached to the ACP [1]. A complete chain extension some modules epimerization must occur to give the final
cycle can involve three more steps: conversion of the alkyl stereochemistry. Exactly how this epimerization is
-ketone group to an alcohol by a ketoreductase (KR), achieved is still unclear. The epimerase activity seems
dehydration by a dehydratase (DH) to form a trans - to reside within the KS domain [7], but there are no
unsaturated acyl intermediate, and finally reduction by obvious differences between the primary sequences of
an enoyl reductase (ER) to give a saturated chain. The epimerizing and nonepimerizing KSs.
condensations between acyl thioesters may be re- KR domains are responsible for determining the final
peated many times, but PKSs rarely take -ketone pro- stereochemistry at chiral centers derived from reduction
cessing all the way to the third stage. As a result, ke- of -ketones to alcohols [8]. Conserved amino acid resi-
tones, hydroxyl groups, and double bonds appear at dues at a few key positions appear to be useful for
defined positions within polyketide chains. predicting KR stereospecificity [9, 10]. Predictive meth-
Chemical and genetic studies have now uncovered ods suggest that the DH domains of modular PKSs nor-
many different types of PKS [2]. Of these, the modular mally act on (3R)-hydroxyacyl chains to give trans dou-
ble bonds. Few complex polyketides have cis doublePKSs are the most amenable to redesign for production
